← Back to Search

Behavioral Intervention

Personalized Chatbot Condition for Cervical Cancer

N/A
Waitlist Available
Led By Xiaoli Nan
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights

Study Summary

This trial tests if an online chatbot can reduce HPV vaccine hesitancy among African American parents, to help inform future communication interventions.

Eligible Conditions
  • Cervical Cancer
  • Penile Cancer
  • Anal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attitudes toward HPV vaccination
Intentions toward HPV vaccination
Secondary outcome measures
Ratings of the Chatbot

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Personalized Chatbot ConditionExperimental Treatment1 Intervention
After reading a standard CDC HPV vaccine message, participants will interact with a chatbot designed to deliver personalized HPV vaccine messages (i.e., tailored to their personalities).
Group II: Non-Personalized Chatbot ConditionExperimental Treatment1 Intervention
After reading a standard CDC HPV vaccine message, participants will interact with a chatbot designed to deliver HPV vaccine messages, which are not tailored to their personalities.
Group III: No Chatbot Control ConditionActive Control1 Intervention
Participants will read a standard CDC HPV vaccine message without interacting with any chatbot that delivers additional messages.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Non-Personalized Chatbot Intervention
2023
N/A
~460
Personalized Chatbot Intervention
2023
N/A
~460

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkLead Sponsor
155 Previous Clinical Trials
45,209 Total Patients Enrolled
Xiaoli NanPrincipal InvestigatorUniversity of Maryland, College Park
1 Previous Clinical Trials
1,170 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants enrolled in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this clinical trial is actively recruiting subjects and has been doing so since July 1st of 2023 with the last update being on 17th of that same month. The research team are aiming for 600 participants from a solitary site."

Answered by AI

Are new applicants still being taken for this research endeavor?

"Affirmative. Clinicaltrials.gov data indicates that this scientific enquiry, which was initialised on July 1st 2023, is still recruiting individuals for participation. 600 patients from one research centre need to be selected for the study."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
2023. "A Chatbot Intervention for Reducing HPV Vaccine Hesitancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05959564.
~261 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top